Market Cap 12.80M
Revenue (ttm) 0.00
Net Income (ttm) -4.79M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 17,700
Avg Vol 426,587
Day's Range N/A - N/A
Shares Out 3.71M
Stochastic %K 61%
Beta 1.71
Analysts Strong Sell
Price Target $32.00

Latest News on BCTX

BriaCell Therapeutics Announces Closing of Public Offering

Feb 5, 2025, 4:05 PM EST - 5 weeks ago

BriaCell Therapeutics Announces Closing of Public Offering


BriaCell Therapeutics Announces Pricing of Public Offering

Feb 3, 2025, 7:59 PM EST - 5 weeks ago

BriaCell Therapeutics Announces Pricing of Public Offering


BriaCell Announces Completion of 15:1 Share Consolidation

Jan 27, 2025, 6:42 PM EST - 6 weeks ago

BriaCell Announces Completion of 15:1 Share Consolidation


BriaCell Therapeutics Announces Proposed Public Offering

Dec 11, 2024, 4:05 PM EST - 3 months ago

BriaCell Therapeutics Announces Proposed Public Offering


BriaCell Provides Update to its Board of Directors

Nov 25, 2024, 7:50 AM EST - 3 months ago

BriaCell Provides Update to its Board of Directors


BriaCell Therapeutics Announces Closing of $5 Million Offering

Oct 2, 2024, 4:05 PM EDT - 5 months ago

BriaCell Therapeutics Announces Closing of $5 Million Offering


BriaCell Therapeutics Announces $5 Million Offering

Oct 1, 2024, 2:05 PM EDT - 5 months ago

BriaCell Therapeutics Announces $5 Million Offering


BriaCell Therapeutics Announces Closing of $8.5 Million Offering

Sep 12, 2024, 4:05 PM EDT - 6 months ago

BriaCell Therapeutics Announces Closing of $8.5 Million Offering


BriaCell Therapeutics Announces $8.5 Million Offering

Sep 11, 2024, 12:09 PM EDT - 6 months ago

BriaCell Therapeutics Announces $8.5 Million Offering


BriaCell Presents Clinical Efficacy Data at ASCO 2024

Jun 3, 2024, 8:00 AM EDT - 10 months ago

BriaCell Presents Clinical Efficacy Data at ASCO 2024


BriaCell Announces Oral and Poster Presentations at ASCO 2024

Apr 24, 2024, 8:00 AM EDT - 11 months ago

BriaCell Announces Oral and Poster Presentations at ASCO 2024